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Epidemiology of adolescent substance use in Norfolk 
schools.  
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Summary  
Background: The pattern of alcohol and substance use is changing, with the introduction of 
novel psychoactive substances, the internet as a means of acquisition and variations in drug 
purity and price. Alcohol and substance use among adolescents is associated with 
behavioural, mental health, health and social difficulties; arising at a vulnerable period in 
their development. Little is known about adolescent substance use in the UK, especially in 
rural areas. Aim: To investigate the prevalence of substance use amongst young people, 
aged 16 -21 years, in Norfolk schools. Design: Cross sectional questionnaire survey. Method: 
Pupils from two sixth form colleges in Norfolk answered a self-report questionnaire 
designed to measure prevalence, age of onset and frequency of use for alcohol, tobacco, 
illicit substances including new psychoactive substances, as well as demographic data. 
Results: 482 students completed the survey (68% participation rate). Life-time use of 
alcohol was reported by 442 (91.7%) students and over half the pupils had tried tobacco 
(52.5%, n=253). 40.7% reported cannabis use and nearly one fifth (18.9%, n=91) reported 
using 3 4-methylenedioxymethamphetamine (MDMA). 41.1% (n=198) students reported 
using ‘any drug’ and 23.2% (n=112) ‘using an illicit drug other than cannabis’. 8.7% (n=42) 
reported the use of a novel psychoactive substance. Conclusion: The most widely used 
substances were alcohol, tobaccos and cannabis; in keeping with European trends. Over the 
past decade a decline in alcohol and drug use by adolescents has been seen in the UK. 
However, since 2010 this decline has slowed with an increase in substance use noted in the 
past two years. This study provides evidence to support this trend. The findings 
demonstrate differences between the use of substances by pupils in this Norfolk sample 
compared to national surveys and more urbanised areas. These regional differences can be 
used to assist the development of local interventions targeting substance use among 
adolescents.   
 
……………………………………………………………………………………………………………………………………………… 
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Introduction 
The European Monitoring Centre for Drugs and Drug Addiction report that one in four young 
European’s aged 15 to 34 years have tried an illicit drug 1 with the UK having the highest 
prevalence for the Class A drugs cocaine and MDMA in Europe 2. Illegal drug use continues 
to be one of the most significant public health challenges in the UK. This is compounded by 
the continually evolving drug climate. Whilst drugs such as cannabis and cocaine remain the 
most widely used drugs 1,3 ; since the mid 2000s New Psychoactive Substances (NPS) 
colloquially known as ‘legal highs’ have appeared on the market 1,4. These drugs are 
potentially harmful 1,5 and in the UK the Psychoactive Substance Act makes it illegal to 
supply NPSs 6. However, attempts to control their use is hampered by their rapid production 
and appearance of an ever increasing variety of new substances 4,5.   
 
The two largest categories of NPS, cathinones and synthetic cannabinoids 1 are most 
commonly used 7-10. In 2014, 60% of NPS seizures in Europe were synthetic cannabinoids. 
As of 2015, 160 synthetic cannabinoids had been identified and these are the largest drug 
group monitored by EMCDDA’s EU Early Warning System 11.  
 
Rates of drug use are higher among young people compared to older people and 
particularly high among adolescents 3,12. Adolescence is a particularly vulnerable time to be 
using substances because young adults are still developing mentally and physically. 
Adolescents are trying substances for the first time, being unaware of how their body will 
respond. This can result in them increasing overdose risk by using higher doses, mixing 
substances and engaging in high risk behaviours including high risk sexual behaviours. Early 
and frequent substance use has been shown to impact upon physical health, mental well-
being, behaviour and educational achievement 13-17. Research demonstrates a positive 
correlation between substance use, in particular cannabis and alcohol, with later mental 
health difficulties such as psychosis, depression and dependence syndromes 18, 24. In 2016 
the UK had highest rate of NPS purchases 7. NPS use has been observed to cause periods of 
acute psychosis 25,26 in addition to tripling the likelihood of needing emergency medical 
treatment 7. 
  
Research into adolescent drug use in the UK has focused predominantly on urban samples 
who have different life experiences to young people who grow up in rural areas. Living in a 
rural location was once thought to be a protective factor against substance misuse due to 
being geographically removed from factors supportive of drug use such as availability and 
crime 27. Some studies report marked differences in the prevalence of drug and alcohol use 
between rural and urban areas, as well as, differences in the prevalence of mental disorders 
28,29. Substance use may be more challenging to address in rural communities with fewer 
resources for prevention and treatment, on top of reduced means of travel. However, rural 
drug users report having close family/social networks to support helping them to avoid 
hitting ‘rock bottom’ 30.   
 
The aim of this study was to investigate adolescent’s use of alcohol, tobacco, illicit drugs 
including NPS in two Norfolk schools amongst adolescents aged 16 to 21.  
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Method 
Research design and data collection tool 
The study was conducted as cross sectional survey using a self-report questionnaire 
developed by Penny et al. (2015) 31. The data gathered included (i) demographics (age, 
gender, ethnicity); (ii) whether the student had heard of alcohol, tobacco and a range of 18 
recreational drugs and NPS; (iii) life-time/last-month use of alcohol, tobacco and these 
drugs; (iv) age of onset of first using substances; (v) whether the respondent reported binge 
drinking (more than 6 units for females or 8 units males in a single session (Office of 
National Statistics, 2015); (vi) if drug use was reported the source of the drug(s). 
 
Sample and research sites 
Purposive sampling was used to identify four non-selective state schools in Norfolk, which 
included students from different socioeconomic groups and spanned the county. The head 
teachers were invited to participate in the study and two agreed to do so. School 1 was a 
large sixth form college in Norwich (a small city with a population of 132,000) with both and 
urban and rural intake from across the county. School 2 was a sixth form attached to a high 
school in a rural area on the coast. Year 12 and 13 were surveyed in these schools, with 
pupils aging from 16–21 years, completing A-levels. Both schools were predominantly white 
(92.1%) in ethnicity. 
 
Data collection procedure 
One member of the researcher team (ER) distributed the questionnaires in person to 
students in class and remained with the students whilst they were completed. Each 
participant was given a study information sheet to decide if they wished to participate and 
was able to contact the researcher after receiving the questionnaire if needed. 
Questionnaires were completed anonymously and placed in a sealed box following 
completion. 
 
Data analysis 
Data were analysed using SPSS Version-20. Data from the two schools were pooled to 
provide a sample of Year 12 (16-17 years) and Year 13 (17–21 years) students. Findings are 
reported as frequencies and percentage prevalence. The chi-squared test of association was 
used to examine relationships between two independent categorical/ordinal variables. A 
multivariable logistic regression model was used to identify which variables from the survey 
influenced reported substance use. The independent variables included in the model were: 
school, gender, year group, alcohol used, SDQ subscale scores (emotional problems, 
conduct problems, hyperactivity, peer problems, prosocial behaviour) and ethnicity (BME or 
white ethnicity). Cox & Snell R
2, 
Nagelkerke R
2
 and percent concordance were used to assess 
model of fit.  
 
Ethical approval 
The research was approved by the King’s College University Research Ethics Committee 
(reference: PNM/14/15-126). 
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Results 
 
Sample and response rate 
A total of 655 students were invited to participate and 482 valid questionnaires completed, 
a response rate of 73.6%. In School 1, 7 pupils (1.4%) declined to participate and 81 (16.7%) 
students were absent from school on the day of study. In School 2, the survey was distributed 
during a sixth form assembly, not allowing for absentees to be recorded.  
 
Respondents comprised of 169 males (35.1%) and 304 females (63.1%), with one participant 
identifying as transgender (0.2%). Eight participants did not record their gender (1.7%). 
Most pupils were in academic Year 12 (n=313, 65%). The most common ages were 17 years 
(40.3%) and 16 years (38.2%), followed by 18 years (16.2%) and 19-21 years (3.9%). The 
ethnic breakdown was predominantly White British n = 417 (86.5%) with all other ethnicities 
observed in smaller percentages. It was therefore decided to refine the ethnicity groupings 
to ‘white’ (n=444, 92.1%) and ‘black and minority ethnic’ (BME) (n=37, 7.7%) and investigate 
variations between these two broad groupings.   
 
Table 1: Demographics of the Norfolk respondents  
 
 School 1  
N (%) 
School 2  
N (%) 
Total 
N (%) 
Gender 
Male 132 (33.2%) 37 (43.5%) 169 (35.1%) 
Female 257 (64.7%) 47 (55.3%) 304 (63.1%) 
Transgender 1 (0.3%) 0 (0.0%) 1 (0.2%) 
Missing 7 (1.8%) 1 (1.2%) 8 (1.7%) 
Year Group 
Year 12 244 (61.5%) 69 (81.2%) 313 (65.0%) 
Year 13 130 (32.7%) 16 (18.8%)  146 (30.3%) 
Missing 23 (5.8%) 0 (0.0%)  23 (4.7%) 
Total  397 (100%) 85 (100%) 482 (100%) 
Ethnicity  
White British 338 (85.1%) 79 (92.9%) 417 (86.5%) 
Other white 22 (5.5%) 5 (5.9%) 27 (5.6%) 
BME 36 (9.1%) 1 (1.2%) 37 (7.7%)  
Missing 1 (0.3%) 0 (0.0%) 1 (0.2%) 
Total 397 (100%) 85 (100%) 482 (100%) 
Age 
16 127 (32.0%)  57 (67.1%) 184 (38.2%) 
17 167 (42.1%) 27 (31.8%) 194 (40.3%) 
18 77 (19.4%) 1 (1.2%) 78 (16.2%) 
19 12 (3.0%) 0 (0.0%) 12 (2.5%) 
20 5 (1.3%) 0 (0.0%) 5 (1.0%) 
21 2 (0.5%) 0 (0.0%) 2 (0.4%) 
Missing 7 (1.8%) 0 (0.0%) 7 (1.5%) 
Total 397 (100%) 85 (100%) 482 (100%) 
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Alcohol use 
A total of 442 (91.7%) reported lifetime use of alcohol. This increased slightly with age with 
Year 13 pupils reporting 93.2% use compared to 91.1% in Year 12. There were no gender 
differences in lifetime use of alcohol between males (91.1%) and females (91.8%). Use was 
higher in white (n=412, 92.8%) than in non-white students (n=29, 78.4%).  
 
A total of 475 (98.5%) respondents answered the question about binge drinking (>6 units for 
females, > 8 units for males). 30.9% (n=149) reported that they never binge drink. Of those 
who reported binge drinking, 41.3% (n=199) reported binge drinking less than once a 
month, 12.2% (n=59) monthly, 11.4% (n=55) weekly and 2.7% (n=13) daily.  
 
Only 8.7% (n=6) of 16 year old males reported not drinking compared to 22.7% (n=25) of 
females. Across all ages more males reported drinking in excess of 10+ units in a single 
drinking session than females (n= 45, 26.8% vs. n=51, 17.2%). More males were also 
drinking on a weekly basis (n=23, 13.7% vs. n=28, 9.5%) or nearly daily (n=7, 4.2% vs. n=7, 
2.4%) compared to females. Yet interestingly more 18 year old males reported abstinence 
than females (n=8, 25.0% vs. n=2, 4.4%). 
 
Tobacco use 
A total of 253 (52.5%) respondents reported lifetime tobacco use. Females reported a 
slightly higher lifetime use (53.3%) than males (51.5%). Year 13 pupils were more likely to 
have tried tobacco than year 12 students (56.2% vs.50.2%). Lifetime tobacco use was more 
common amongst non-white (56.8%) than white (52.9%) students.   
 
Familiarity with drugs and NPS  
As shown in Table 2, the drugs most commonly heard of (excluding alcohol and tobacco) 
were cannabis (99.6%), ecstasy (97.7%), heroin (97.7.%), crack cocaine (97.1%) and 
mushrooms (96.3%).The least well-known drugs were gamma-hydroxybutyrate 
(GHB)/gamma-butyrolactone (GBL) (33.0%), khat (38.4%), methoxetamine (43.8%) and spice 
(47.7%). 
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Table 2 Familiarity with alcohol, tobacco and drugs by gender, age and ethnicity 
 
‘Have you heard 
of…’ 
Male  
n=169 
35.1% 
Female 
n= 304  
63.1% 
Year 12 
n = 313  
65.0% 
Year 13 
n= 146  
30.3% 
‘White’ 
n=444  
92.1% 
‘BME’ 
N=37 
7.9% 
Alcohol 168 (99.4%) 304 (100.0%) 313 (100.0%) 145 (99.3%) 443 (99.8%) 37 (100.0%) 
Tobacco 168 (99.4%) 303 (99.7%) 312 (99.7%) 145 (99.3%) 443 (99.8%) 37 (100.0%) 
Cannabis 168 (99.4%) 303 (99.7%) 313 (100.0%) 144 (98.6%) 442 (99.6%) 37 (100.0%) 
Ecstasy 164 (97.0%) 299 (98.4%) 303 (96.8%) 145 (99.3%) 437 (98.4%) 33 (89.2%) 
Heroin 164 (97.0%) 299 (98.4%) 305 (97.4%) 143 (97.9%) 437 (98.4%) 33 (89.2%) 
Crack 163 (96.4%) 297 (97.7%) 304 (97.1%) 142 (97.3%) 433 (97.5%) 34 (91.9%) 
Mushrooms 162 (95.9%) 294 (96.7%) 299 (95.5%) 143 (97.9%) 430 (96.9%) 33 (89.2%) 
Acid 165 (97.6%) 289 (95.1%) 298 (95.2%) 141 (96.6%) 427 (96.2%) 34 (91.9%) 
Cocaine 162 (95.9%) 292 (96.1%) 300 (95.8%) 139 (95.2%) 427 (96.2%) 34 (91.9%) 
Speed 157 (92.9%) 289 (95.1%) 289 (92.3%) 143 (97.9%) 420 (94.6%) 33 (89.2%) 
Ketamine 159 (94.1%) 277 (91.1%) 285 (91.1%) 137 (93.8%) 416 (93.7%) 27 (73.0%) 
Crystalmeth 156 (92.3%) 266 (87.5%) 272 (86.9%) 136 (93.2%) 398 (89.6%) 30 (81.1%) 
Solvents  141 (83.4%) 244 (80.3%) 245 (78.3%) 127 (87.0%) 367 (82.7%) 24 (64.9%) 
MDMA 136 (80.5%) 223 (73.4%) 228 (72.8%) 119 (81.5%) 342 (77.1%) 24 (64.9%) 
Mephedrone 128 (75.7%) 221 (72.7%) 220 (70.3%) 114 (78.1%) 332 (74.8%) 23 (62.2%) 
Poppers 119 (70.4%) 184 (60.5%) 187 (59.7%) 105 (71.9%) 287 (64.6%) 21 (56.8%) 
Spice  83 (49.1%) 143 (47.0%) 147 (47.0%) 72 (49.3%) 216 (48.7%) 15 (40.5%) 
Methoxetamine 77 (45.6%) 130 (42.8%) 133 (42.5%) 66 (45.2%) 197 (44.3%) 15 (40.5%) 
Khat 73 (43.2%) 107 (35.2%) 127 (40.6%) 47 (32.2%) 175 (39.4%) 13 (35.1%) 
GHB 55 (32.5%) 102 (33.6%) 97 (31.0%) 54 (37.0%) 149 (33.6%) 13 (35.1%) 
 
 
Drug use 
A total of 198 students (58.9%) reported lifetime drug use. Cannabis was the most 
commonly used drug (n=198, 41.7 %), followed by MDMA (n =91, 18.9%) and speed (n =48, 
10%). As shown in Table 3, reported lifetime prevalence of the use of cannabis and other 
drugs increased with school year. Overall, 23.2% (n=112) reported use of an illicit drug other 
than cannabis. The prevalence of cannabis use was higher among white respondents (n 
=185, 50.7%) than non-white pupils (n=11, 29.7%). There were no gender differences in use 
of cannabis (40.8% vs. 40.8%). However, the use of ‘any illicit drug’ was slightly higher in 
males than females (43.2% vs. 40.1%) and males also reported higher use of ‘any drug other 
than cannabis’ than females (27.2% vs. 21.7%).  
 
The number of respondents reporting NPS use was 8.7% (n=42), which made this one of the 
Norfolk pupils’ top 10 most used drug groups. The most commonly used NPS were 
Mephedrone (n= 31, 6.4%), synthetic cannabinoid receptor agonists (‘Spice’) (n = 21, 4.4%), 
and methoxetamine (n= 4, 0.8%). In response to the question which asked respondents if 
they had taken any drugs not listed in the survey, the most frequently reported additional 
drugs used were NPS and ‘legal highs’. Unfortunately, these could not be incorporated into 
the data set due to broad descriptions e.g. ‘legal highs’.   
 
Amongst students reporting life-time drug use (n=198), the most common source of supply 
was from a friend (n=149, 30.9%) followed by a dealer (n=104, 21.6%) a shop (n=55, 11.2%) 
and family member (n=33, 6.6%); use of the internet for supply was less common (n=12, 
2.5%). 
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Table 3, Prevalence of overall substance use, by gender and age. 
 
Overall ranking 
‘have you ever 
used…’ 
Substance Overall 
totals 
Male 
 
N=169 
Female 
 
N=304 
Year 12 
 
N=313 
Year 13 
 
N=146 
1 Alcohol 442 (91.7%) 154 (91.1%) 279 (91.8%) 285 (91.1%) 136 (93.2%) 
2 Tobacco 253 (52.5%) 87 (51.5%) 162 (53.3%) 157 (50.2%) 82 (56.2%) 
3 Cannabis 196 (40.7%) 69 (40.8%) 124 (40.8%) 120 (38.7%) 64 (43.8%) 
4 MDMA 91 (18.9%) 37 (21.9%) 54 (17.8%) 54 (17.3%) 31 (21.2%) 
5 Speed 48 (10%) 22 (13.0%) 26 (8.6%) 29 (9.3%) 15 (10.3%) 
6 Ecstasy 47 (9.8%) 26 (15.4%) 21 (6.9%) 21 (8.6%) 16 (11.0%) 
7 Cocaine 43 (8.9%) 18 (10.7%) 25 (8.2%) 23 (7.3%) 17 (11.6%) 
8 Poppers 36 (7.5%) 23 (13.6%) 13 (4.3%) 23(7.3%) 12 (8.2%) 
9 Acid 35 (7.3%) 16 (9.5%) 19 (6.3%) 22 (7.0%) 11 (7.5%) 
10 Ketamine 34 (7.1%) 18 (10.7%) 16 (5.3%) 16 (5.1%) 16 (11.0%) 
11 Mephedrone 31 (6.4%) 15 (8.9%) 16 (5.3%) 18 (5.8%) 11 (7.5%) 
12 Mushrooms 26 (5.4%) 13 (7.7%) 14 (4.3%) 16 (5.1%) 8 (5.5%) 
13 Spice 21 (4.4%) 12 (7.1%) 9 (3.0%) 10 (3.2%) 8 (5.5%) 
14 Solvents 14 (2.9%) 8 (4.7%) 6 (2.0%) 9 (2.9%) 4 (2.7%) 
15 Crystalmeth 9 (1.9%) 5 (3.0%) 4 (1.3%) 7 (2.2%) 1 (0.7%) 
16 Crack 6 (1.2%) 3 (1.8%) 3 (1.0%) 4 (1.3%) 2 (1.4%) 
17 Heroin 5 (1.0%) 2 (1.2%) 3 (1.0%) 4 (1.3%) 1 (0.7%) 
18 Methoxetamine 4 (0.8%) 1 (0.6%) 3 (1.0%) 3 (1.0%) 1 (0.7%) 
19 Khat 3 (0.6%) 2 (1.2%) 1 (0.3%) 3 (1.0%) 2 (1.4%) 
20 GHB 3 (0.6%) 1 (0.6%) 2 (0.7%) 2 (0.6%) 1 (0.7%) 
 Any drug 198 (41.1%) 73 (43.2%) 122 (40.1%) 124 (39.6%) 63 (43.2%) 
Any drug other 
than cannabis 
112 (23.2%) 46 (27.2%) 66 (21.7%) 68 (21.7%) 37 (25.3%) 
NPS * 42 (8.7%) 19 (11.2%) 23 (7.6%) 23 (7.3%) 16 (11.0%) 
*NPS = Spice, Mephedrone and Methoxetamine 
 
Influences on drug use 
 
Few differences were observed in overall substance use by individual schools, except that 
students in School 1 reported higher levels of NPS use than in School 2 (9.8% vs. 3.5%). 
There was some gender variation within the schools, with School 2 females reported lower 
illicit substance use than males (31.9 % vs.45.9%) whereas this was not significant in School 
1 (41.6% vs. 42.4%). For ‘any drug used excluding cannabis’ females reported lower use than 
males in both schools, although usage remained higher in School 1 compared to School 2 
(23.7% vs. 10.6%). Prevalence was similar for males in both schools (27.3% vs. 27.0%).  
 
The fit o the overall multivariable logistic regression model was statistically significant χ2 
(with 11 degrees of freedom) = 56.11, p<.001, indicating that the model was able to 
differentiate to some degree between pupils who reported and did not report substance 
use. The Cox Snell R
2
 was 11.3% and Nagelkerke R
2
was 15.2%. The model correctly classified 
65.2% cases and accurately predicted 82% of non-users and 41% of users. The odds ratios 
and 95% confidence intervals estimated from the model are shown in Table 4. Both use of 
alcohol and conduct problems were associated with reported drug use.  
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Table 4: Multivariable logistic regression model for reported drug use 
 
      
Variable Odds ratio(95% CI) p 
      
School 
 
  
  School 1 1.00 (-)   
  School 2 0.79 (0.46-1.36) .40 
  
 
  
Gender 
 
  
  Male 1.00 (-)   
  Female 1.00 (0.63-1.57) .99 
  
 
  
Year group (Wald χ2 =1.13, 2df, p=.57) 
  12 1.00 (-)   
  13 1.02 (0.66-1.58) .92 
  Unknown 1.71 (0.63-4.64) .29 
  
 
  
Alcohol used 
 
  
  No 1.00 (-)   
  Yes 7.22 (2.14-24.32) .001 
  
 
  
SDQ 
 
  
  Emotional problems 0.95 (0.87-1.04) .29 
  Conduct problems 1.32 (1.14-1.53) <.001 
  Hyperactivity 1.06 (0.96-1.17) .22 
  Peer problems 0.89 (0.79-1.01) .075 
  Prosocial behaviour 0.99 (0.89-1.11) .92 
  
 
  
Ethnicity 
 
  
  BME 1.00 (-)   
  White ethnicity 1.63 (0.74-3.62) .23 
      
 
 
Discussion 
 
There are few studies addressing substance use by adolescents in the UK and no previous 
known studies in Norfolk. This section discusses the findings of the study compared to wider 
research literature and data from London schools where the same self-report questionnaire 
was distributed. 
 
Alcohol 
Among Norfolk student’s the most used substance was alcohol, with 91.7% having tried it. 
The European School Survey Project on Alcohol and Drugs (ESPAD) 2 survey reported 90% 
prevalence, similar to those in this study. Norfolk adolescents reported a significantly higher 
prevalence than adolescents in Penney’s London sample where 47.8% had used alcohol 31. 
This may be due to the cultural and religious diversity in London. Variations in substance use 
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have been attributed to stronger familial relationships and faith within ethnic minorities and 
peer influences and school cultures being more influential upon white than non-white 
individuals 32-35. These findings are supported in the English Smoking, Drinking and Drug use 
survey (SDD) 36, who observed lowest drinking rates in London. Interestingly, when looking 
at white students in both Norfolk and London, Norfolk students continued to report higher 
alcohol use than in London (92.8% vs.79.7%). Alcohol was a strong predictor of other 
substance use. Alcohol has been described as a ‘gateway drug’ leading to higher levels of 
licit and illicit substance use 37.  
 
Tobacco 
In this study 52.5% of pupils reported lifetime smoking. This is higher than national 
prevalence which ranges from 24% - 47% 2,15,36. A lower proportion of pupils in Norfolk 
reported tobacco use compared to those in Penney’s London study where there was a 
69.1% reported prevalence 31. Findings from this and Penney’s London study are at odds 
with the perceived decline in smoking in England since the mid-1990’s 2. The health and 
wellbeing ‘What About Youth’ survey 38 noted a gender difference in tobacco use with girls 
being more likely than boys to have smoked (28% vs. 21%); this was subtly seen among 
Norfolk pupils (53.3% vs. 51.5% respectively). This possibly indicates that smoking is more of 
a cultural norm in Norfolk, with fewer gender barriers. Norfolk students’ rates of tobacco 
use increased with age, a pattern supported by the SDD, ESPAD and WAY surveys.  
 
Illicit drug use 
41.1% of students in Norfolk said they had used ‘any drug’. This is higher than figures 
collected by the EMCDDA (2016) reporting 36.5% use of ‘any illegal drug’ by 15-24 year olds, 
the ESPAD survey (24%), Penney’s London study (20.4%) and the SDD survey of 11-15 year 
olds (15%). When comparing white students’ from this study to white students in the 
London study who completed the same questionnaire, Norfolk students’ use continued to 
be higher (42.1% vs. 25.3%). These finding goes against the overall pattern of decreasing 
substance use. It supports the recent trend of substance use increasing over the past few 
years; with the Crime Survey for England and Wales (2015) 3 reporting illicit drug use rose 
from 16.4% in 2012/13 to 19.4% in 2014/15. The higher prevalence in Norfolk may result 
from the schools’ culture towards substance use, normalisation and peers attitudes 39-41. 
The WAY survey found the lowest score on the Warwick-Edinburgh Mental Well-Being Scale 
42 for ‘life satisfaction’ was in the East of England. Poor mental well-being increases the 
likelihood of using substances under the self-medication theory. These findings also support 
the claim that substance use is more prevalent in rural areas than urban settings 43-46.  
 
Cannabis was the most commonly used illicit drug, with 41.7% of Norfolk adolescents 
reporting lifetime use, this is in keeping with the European and UK figures 1,12, 31,47. 
However, rates of use in Norfolk were considerably higher than reported elsewhere; ESPAD 
(25%), Penney et al. (17.4%), SDD (18.7%) and WAY (11%). When comparing white 
respondents in this and Penney’s London study, Norfolk students reported use remained 
significantly higher (50.7% vs. 20.3%). No variation was seen between males and females for 
cannabis use. This contrasts with findings from European surveys which find that males 
were twice as likely as females to report use of cannabis and exhibit more intensive and 
regular use 1.  
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Use of ‘any drug other than cannabis’ was reported by 23.2% of Norfolk adolescents. The 
most commonly used drugs after Cannabis were MDMA (18.9%), Speed (10.0%) and Ecstasy 
(9.8%). Reports of ‘other’ drug use were not shown for the UK in ESPAD (2015) key findings, 
yet, ecstasy and amphetamines were joint second across Europe. Regional preferences were 
observed amongst commonly used drugs other than cannabis. The SDD reported solvents 
being the most used substance after cannabis, with prevalence of other substance use being 
low 36, where as in the London study magic mushrooms and amphetamines were more 
prevalent. In the London study 31 only 6.9% reported trying any ‘drug other than cannabis’ 
highlighting the volume reported in this study. 
 
18.9% of Norfolk pupils had used MDMA. This is a much higher prevalence than the 10.2% 
use reported by EMCDDA (2014); the 5.4% use by 16-24 year old in the CSEW (2014/15); or 
the 0.9% prevalence in Penney’s London survey 31.  
 
The use of NPS was reported by 8.7% of Norfolk respondents. This is considerably higher 
than the national average of 2.8% 3 and the 1.1% prevalence in Penney’s London study 31. 
The most common NPS in Norfolk was Spice (4.4%).  Norfolk student’s reported a higher use 
of Mephedrone (6.4 %), compared to the SDD survey (1.3%), which also did not ask about 
other NPS use, and Mephedrone use in the London study (0.5%) 31. Therefore this study 
supports the rise in NPS use across Europe 1 and highlights the existence of regional 
differences. 
  
 
Factors associated with substance use 
 
Identifying factors linked to drug use promotes a greater understanding of potential 
influences that could help shape preventative interventions. This study identified 
demographic factors associated with drug and alcohol use.  
 
Age 
Substance use was seen to increase incrementally with age, supported by the SDD, ESPAD 
and the London study 2, 12, 31. Key ages for trying substances in the Norfolk sample were 
between 12-16 years for alcohol, tobacco and cannabis and 14-18 years for MDMA. It has 
been noted that alcohol use at 11–14 years heightens the risk of developing of alcohol 
disorders 48. Research shows that progression of drug use usually begins with a legal 
substance, with early alcohol use being a strong factor in later illegal drug use 37.  
 
Ethnicity 
A high percentage of Norfolk adolescents reported lifetime alcohol use, whereas a 
comparatively low percentage of London students reported alcohol use. Factors which could 
lead to this difference may include ethnicity, culture, and religion.  Stronger familial ties 
have been seen to influence BME adolescents, with peer influences having a stronger affect 
upon white respondents 49.  
 
Tobacco use was reported less in Norfolk than by adolescents in Penney’s London 31. A 
higher tobacco use was also evident amongst BME pupils in Norfolk (56.8% vs 52.9%) which 
was also seen the London study.  
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 Gender 
Only marginal gender differences were seen between the ages of onset for substances, 
except for MDMA among Norfolk adolescents. Conversely, going against the trend of males 
being more likely to try illegal substances, it was females who showed a higher uptake of 
MDMA at age 15 (31.4%, n=16 vs. 10.8%, n=4). 
 
Drug source 
 
The most frequently reported method of obtaining illicit substances was from a friend 
(30.9%), followed by a dealer (21.6%), shop (11.2%) and over the internet (2.5%). This 
supports findings from the CSEW (2015) 3 and reflects the trend seen among white 
respondents in Penney et al.’s (2016) London study 31. Whereas, Black and Asian 
respondents’ in London primarily sourced substances from a dealer or shop respectively 31.  
Male students were nearly twice as likely to obtain drugs from a shop and were slightly 
more likely to use a dealer or the internet compared to female peers. Norfolk pupils 
reported slightly higher rates of obtaining drugs over the internet (2.5%), in comparison to 
1% in the CSEW (2014) and 0.5% in Penney et al.’s London study. Use of the internet as a 
means of acquisition may be less than other sources as it is believed such websites are 
predominantly used by people in their 20-30s 50. The low use of ‘head shops’ could be 
attributed to not wanting a ‘drug user identity’ as reported by some Mephedrone users 51. 
Since this study was conducted, The Psychoactive Substances Act was introduced in 2016, 
making it illegal for these shops to exist, pushing their sales underground. As a result, NPS 
sourcing may increase over the dark web 52 and users may become more reliant on drug 
dealers. 
 
Limitations 
 
The sample was limited to 482 respondents and included just two schools. The sample also 
included only sixth form student’s studying for A-levels. Data collection was limited to 
students present on the day of sampling, since teachers did not want questionnaires to be 
sent to students’ homes. From conversations with teachers, some of the truanting students 
were known to have substance misuse problems and therefore the reported use of 
substances in this sample may be an underestimate. 
 
The sample was predominantly white which made comparison with other ethnicities 
unreliable. From the 2011 census 92.4% of Norfolk inhabitants were ‘white British’ making 
the sample representative, however, recent figures may have changed because of EU 
migration into the local agricultural workforce. 
 
The multivariable model only accurately predicted drug use in 65% of cases. It was better at 
predicting non-users than users. There may be an element of reverse causality in the model 
with behavioural problems being caused by drug use.  
 
There are also limitations in drawing comparisons between this data set, collected in 2016, 
and those from other research carried out at different times. This is due to the rapidly 
changing drug scape as well as changes in educational legislation passed in 2015 by the 
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Department of Education, with young people now remaining in educational/vocational work 
until the age of 18 years. Research conducted before 2015 may have samples which are 
over represented by those wanting to remain in education.  
 
Some respondents gave descriptive answers rather than the numerical ones, for example 
stating they used ‘loads’ of a substance. These data could not be included and therefore this 
may have caused under reporting actual prevalence.  
 
Other factors not captured in this study, such as personal motivation, schools culture and 
peer attitudes 41. If a culture of substance use exists, exposure to drug use will be common 
and perhaps socially desirable.  
 
 
Conclusion 
 
This study showed that alcohol and tobacco were the most used drugs by Norfolk 
adolescents. Cannabis was the most frequently tried illicit drug, which is in keeping with 
European and national figures. Overall, 41.1% of Norfolk student’s reported ‘any drug’ use, 
which was higher than national reported prevalence. The three most used substances after 
cannabis in this study were MDMA, speed and ecstasy. They differed from those identified 
in other research, highlighting regional difference. Use of NPS within the Norfolk sample 
(8.7%) is higher than the national average (2.8%) 3. This study supports the findings that 
rural drug use is equal to and can surpass that of urban drug use. It is additionally supportive 
of a rise in drug use over the past few years 1,3. However, reasons leading to or associated 
with substance use are not be as simple as ‘rural’ and ‘urban’, with no rural or urban area 
being homogenous 53. Causal reasons for drug use are multifaceted, including 
socioeconomic factors, accessibility, cultural influences, religion and varying health 
provisions. Nevertheless, continuing to research adolescent substance use by is vital in 
highlighting recent prevalence trends, identifying the most at risk groups and regional 
differences. This information can be used to inform and shape preventative interventions, 
policy and tailor resources national and locally to meet the target populations need.  
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